Research To Practice | Oncology Videos

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers — Facutly Presentation 1: Hepatocellular Carcinoma — Dr Ghassan Abou-Alfa CME information and select publications

Featuring perspectives from Ms Jamie Carroll, Dr Virginia Kaklamani, Dr Joyce O'Shaughnessy and Mr Ronald Stein, including the following topics: Introduction (0:00) ER-Positive, HER2-Negative Localized Breast Cancer — Part 1 (7:12) ER-Positive, HER2-Negative Localized Breast Cancer —Part 2 (26:18) ER-Positive Metastatic Breast Cancer (37:16) Localized HER2-Positive Breast Cancer (49:27) HER2-Posit...

Featuring perspectives from Ms Paula J Anastasia, Dr Michael J Birrer, Ms Jennifer Filipi and Dr Brian M Slomovitz, including the following topics: Introduction (0:00) Overview of Endometrial Cancer (9:50) Management of Microsatellite Instability-High Endometrial Cancer (23:40) Management of Microsatellite-Stable Endometrial Cancer (33:32) Clinical Trials in Endometrial Cancer (50:04) Systemic The...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer Faculty Presentation 2: Other Therapeutic Considerations in CRC — Dr Pashtoon M Kasi CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer Faculty Presentation 1: Targeted Therapy for Colorectal Cancer (CRC) — Dr Wells A Messersmith CME information and select publications

Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith, including the following topics: Introduction (0:00) Overview of Endometrial Cancer (9:50) Management of Microsatellite Instability-High Endometrial Cancer (23:40) Management of Microsatellite-Stable Endometrial Cancer (33:32) Clinical Trials in Endometrial Cancer (50:04) Systemic Therapy for Cervical Cancer — Immunotherapy (1...

Featuring perspectives from Drs Andrew J Armstrong and Rana R McKay, including the following topics: Introduction (0:00) Intensification of endocrine therapy: Emerging role in nonmetastatic disease; choice of androgen deprivation therapy (3:31) Management of castration-resistant M0 disease; PROTACs, CDK4/6 inhibitors and other new endocrine approaches (16:18) Hormone-sensitive metastatic disease —...

Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity — Faculty Presentation: Dr Daniel Petrylak Visit our website for more publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer — Faculty Presentation 2: Advances in the Care of Patients with Nonmetastatic NSCLC and Small Cell Lung Cancer — Dr Luis Paz-Ares CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer — Faculty Presentation 1: Management of Metastatic Non-Small Cell Lung Cancer (NSCLC) without an Actionable Mutation — Dr Heather Wakelee CME information and select publications

Featuring perspectives from Drs Luis Paz-Ares and Heather Wakelee, including the following topics: Introduction: Looking Back at Immuno-oncology Therapies (0:00) Metastatic Disease (7:46) Localized Non-Small Cell Lung Cancer (42:16) Small Cell Lung Cancer (59:48) CME information and select publications

Featuring perspectives from Dr Sara A Hurvitz, including the following topics: Introduction: Antibody-Drug Conjugates in Breast Cancer (0:00) Case: A premenopausal woman in her late 40s with 0.8-cm ER/PR-positive, HER2-negative invasive ductal carcinoma (IDC) with 2 positive nodes and an Oncotype DX® Recurrence Score® (RS) of 9 — Ranju Gupta, MD (13:59) Case: A premenopausal woman in her early 40s...

Featuring perspectives from Drs Robert L Coleman, Matthew A Powell and Brian M Slomovitz, moderated by Dr Shannon N Westin, including the following topics: Immune Checkpoint Inhibitors for Patients with Advanced Microsatellite Instability (MSI)-High/Mismatch Repair (MMR)-Deficient Endometrial Cancer — Dr Powell  Introduction (0:00) Case: A woman in her early 60s with MSI-high recurrent endometrioi...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes — Faculty Presentation 2: Myelodysplastic Syndromes — Dr Uma Borate, MD, MS CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes — Faculty Presentation 1: Acute Myeloid Leukemia — Prof Andrew H Wei CME information and select publications

Featuring perspectives from Dr Uma Borate and Prof Andrew Wei, including the following topics: Introduction (0:00) Acute Myeloid Leukemia (AML): Key Papers and Presentations (3:30) Myelodysplastic Syndromes (MDS): Key Papers and Presentations (36:32) CME information and select publications

Featuring perspectives from Dr Jacob Laubach, including the following topics: Evolution of first-line treatment for multiple myeloma (MM) (0:00)  Perspectives on the future of bispecific antibody and chimeric antigen receptor (CAR) T-cell therapy for the management of MM (13:27) ASH 2022 updates on front-line management of MM for transplant-ineligible patients (18:35) ASH 2022 updates on the use o...

Featuring perspectives from Dr Matthew Milowsky and Prof Thomas Powles, including the following topics: •       Introduction (0:00) •       Renal Cell Carcinoma (3:23) •       Urothelial Bladder Cancer (35:05) CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer — Faculty Presentation 2: Urothelial Bladder Cancer — Matthew Milowsky, MD CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer — Faculty Presentation 1: Kidney Cancer — Prof Thomas Powles CME information and select publications

Featuring perspectives from Drs Mansoor Raza Mirza, Amit M Oza and Richard T Penson, moderated by Dr Joyce F Liu, including the following topics: •       Optimal Genomic Evaluation of and Targeted Therapies for Newly Diagnosed Advanced Ovarian Cancer — Dr Mirza o   Introduction (0:00) o   Case: A morbidly obese woman in her mid 40s who is a Jehovah's Witness with ovarian cancer and a germline BRCA...

Featuring an interview with Dr John Allan, including the following topics: •       Update on key studies of acalabrutinib in the front-line setting (0:00) •       Updated data from the GLOW study: First-line fixed-duration ibrutinib and venetoclax compared to chlorambucil and Obinutuzumab (21:11) •       Treatment outcomes after achieving undetectable minimal residual disease (MRD) with first-line...

Featuring perspectives from Dr John Strickler, including the following topics: •       Introduction: ASCO Guidelines for the Treatment of Metastatic Colorectal Cancer (0:00) •       Case: A woman in her mid 70s with metastatic colon cancer — Sunil Gandhi, MD (11:14) •       Case: A man in his late 70s with T3N0 MSS adenocarcinoma of the colon who is ctDNA-negative after colectomy and would like to...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer — Faculty Presentation 2: Evidence-Based Utilization of Other Therapeutic Approaches — A Oliver Sartor, MD CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer — Faculty Presentation 1: Optimizing the Use of Hormonal Therapy in Prostate Cancer Management — Tanya B Dorff, MD CME information and select publications